IMMUNOMODULATION FOLLOWING TRANSFUSION

输血后的免疫调节

• 批准号: 7531194
• 负责人: KAREN A NELSON
• 金额: $ 53.88万
• 依托单位: BLOODWORKS
• 依托单位国家: 美国
• 财政年份: 2007
• 资助国家: 美国
• 起止时间: 2007-09-01 至 2010-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7531194
• 关键词: Affect; Allogenic; Alloimmunization; Animal Model; Antibodies; Antibody Formation; Antigen Receptors; Antigen-Presenting Cells; Apoptotic; Attention; Autoimmune Diseases; Autoimmunity; B-Cell Activation; Biological Assay; Blood; Blood Platelets; Blood Transfusion; Blood and Blood Products; Blood donor; Blood specimen; CD4 Positive T Lymphocytes; CTLA4 gene; Cardiac Surgery procedures; Cell Lineage; Cell physiology; Cell surface; Cells; Cellular Immunity; Class; Clinical; Clinical Research; Cohort Studies; Collecting Cell; Colon Carcinoma; Complement; Complication; Condition; Data; Dendritic Cells; Doctor of Medicine; Donor person; Down-Regulation; Effector Cell; Elements; Epitopes; Erythrocytes; Exposure to; Flow Cytometry; HLA Antigens; HLA-DR Antigens; Haplotypes; Health Care Costs; Healthcare; Hospitalization; Human; IL2RA gene; Immune; Immune response; Immunity; Immunocompetent; Immunoglobulin G; Immunoglobulin M; Immunologics; Immunosuppression; Immunosuppressive Agents; Incidence; Individual; Infection; Inflammatory; Interleukin-10; Isoantibodies; Kidney Transplantation; Knowledge; Length; Leukocytes; Link; Lymphocyte; Malignant Neoplasms; Measurement; Measures; Mediating; Mononuclear; Neoplasm Metastasis; Normal Cell; Numbers; Operative Surgical Procedures; Outcome; Patient Care; Patients; Peptides; Peripheral; Personal Satisfaction; Phenotype; Platelet Transfusion; Play; Policies; Polymerase Chain Reaction; Population; Postoperative Period; Principal Investigator; Production; Prospective Studies; Proteins; Randomized Controlled Clinical Trials; Range; Rate; Recurrence; Regulator Genes; Reporting; Research; Research Personnel; Rest; Role; Sampling; Sensitivity and Specificity; Severities; Sorting - Cell Movement; Standards of Weights and Measures; T-Lymphocyte; Testing; Therapeutic immunosuppression; Transforming Growth Factor beta; Transfusion; Transplantation; United States Food and Drug Administration; Upper arm; alpha-galactosylceramide; chemotherapy; cohort; cost; cytokine; enzyme linked immunospot assay; human subject; immunoregulation; immunosuppressed; irradiation; kidney allograft; peripheral blood; programs; response; tumor